Establishing the Ethical Imperative in Psychedelic Medicine

Researchers to Hone In On Most Therapeutic Doses of LSD

New research is looking into the optimal dose of LSD to further enhance the therapeutic benefits of the psychedelic.
Awakn Life Sciences Psychedelics

U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction

Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.
Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores.
Predicting Psychedelic Experience Outcomes Through Machine Learning

Algernon to Investigate DMT Microdose for Stroke Treatment

Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.
Ketamine Therapy May Help Slow Progression of ALS

Ketamine Therapy May Help Slow Progression of ALS

New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis.
Beckley Psychtech Explores Psilocybin for Headache Treatment

Beckley Psytech Explores Psilocybin for Headache Treatment

,
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.
Are 'Magic' Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits

Are ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits

New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.
Are Microdosing Benefits Real? A New Study Says It May All Be In Your Mind

Are Microdosing Benefits Real? A New Study Says It May All Be In Your Mind

,
MIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked just as well.
First Of Its Kind $10 Million Psychedelic Research Center Comes to NYU

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

,
NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.
Study: 69% of Suicidal Patients Saw 'Significant' Improvement With Ketamine Therapy

Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy

,
A new study links ketamine therapy to a significant reduction in thoughts of suicide for 69 percent of study participants.